Pulse Biosciences, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Pulse Biosciences, Inc. (PLSE) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $21.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-19
- Pulse Biosciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $21.70M, a 85.47% increase from fiscal 2024.
- Pulse Biosciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $11.70M, a 44.44% increase from fiscal 2023.
- Pulse Biosciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $8.10M, a 25.00% decline from fiscal 2022.
- Pulse Biosciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $10.80M, a 36.47% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $21.70M 10-K · filed 2026-02-19 |
| 2024-12-31 | $11.70M 10-K · filed 2026-02-19 |
| 2023-12-31 | $8.10M 10-K · filed 2025-03-31 |
| 2022-12-31 | $10.80M 10-K · filed 2024-03-28 |
| 2021-12-31 | $17.00M 10-K · filed 2023-03-31 |
| 2020-12-31 | $21.60M 10-K · filed 2022-03-31 |
| 2019-12-31 | $7.70M 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |